Ruili Port on the China-Myanmar border has fully resumed the customs clearance of the first batch of imported raw materials of traditional Chinese medicine.

1.After being infected with COVID-19, the elderly should be alert to fall easily.

Due to the weakening of muscle strength, the coordination and stability of walking gait of the elderly are reduced, and it is easy to fall in daily life. During the Spring Festival, some elderly people are still recovering from COVID-19 infection, and they are relatively weak. In addition, they may be more excited. More attention should be paid to avoiding falls.

Don’t rush to pick up the old man after he falls, but distinguish the situation and deal with it differently. Also, do not easily move, shake or try to wake the fallen person to avoid aggravating the injury. If the old man is not conscious after falling, he should immediately call the emergency telephone and take appropriate emergency measures. First move the elderly to a safe environment, and immediately implement cardiopulmonary resuscitation in case of respiratory and cardiac arrest; If there is obvious trauma and bleeding, immediately press and stop bleeding and bandage the wound; If the old man suffers from head injury, ear and nose bleeding, or suspected skull base fracture, he should lie down quietly and keep the respiratory tract unobstructed.

If the old man is conscious after falling, his family should comfort the old man, carefully ask the specific process of the old man’s injury and his current discomfort, observe the injured part and whether there is bleeding, check the old man’s trunk and limbs, and preliminarily determine whether there is fracture.

2.Ruili Port on the China-Myanmar border has fully resumed the customs clearance of the first batch of imported raw materials of traditional Chinese medicine.

The reporter learned from the Ruili entry-exit border inspection station on the 28th that at 18:00 on the 27th, with a truck loaded with imported raw materials of traditional Chinese medicine slowly driving into Ruili port from Mujie, Myanmar, the driver of the original truck directly handled the entry-exit formalities, marking that after the first batch of entry-exit passengers successfully cleared from Ruili port on January 25, the cross-border cargo transport between China and Myanmar at the port after nearly three years has also fully returned to the normal management before the epidemic.

“At present, the cross-border cargo transportation at Ruili Port has eliminated the segments of transportation, transfer and disinfection and sterilization, simplified the customs clearance process, shortened the customs clearance time, and significantly improved the speed of customs clearance. The border inspection authorities will also continue to optimize measures, strengthen communication with joint inspection units and import and export enterprises, and ensure that vehicles pass the customs with” zero waiting “and the inspection process with” zero delay “.” Introduction by the relevant person in charge of Ruili entry-exit border inspection station.

At the scene of customs clearance, Huang Hongxing, the receptionist of this batch of imported Chinese herbal medicine goods receiving enterprise, said, “I am very excited to see the trucks enter the country. In the future, the orders of enterprises will increase, and the income of our cross-border freight staff will also increase.”

It is understood that the first batch of imported raw materials of traditional Chinese medicine is 20 tons of Chinese medicinal materials of Vitex trifolia and Terminalia chebula approved by the state. Next, the batch of raw materials of traditional Chinese medicine will be sold to pharmaceutical enterprises all over the country.

Ruili Port, located at the border of Yunnan Province, is a national Class I port and the largest land port with the largest volume of inbound and outbound traffic and the largest volume of trade between China and Myanmar. It is composed of three channels with different functions, namely, the national gateway channel, the China-Myanmar Street channel and the cargo yard channel, and is responsible for the entry-exit inspection of personnel (including official and passport holders), motorcycles and small vehicles, trucks and large vehicles.

3.The number of new recurrent cases of leprosy prevention and treatment in Guangxi has been significantly reduced

January 29 is the 70th “World Leprosy Prevention Day” and the 36th “China Leprosy Festival”. The Guangxi Zhuang Autonomous Region Health and Health Commission actively organized leprosy science publicity in various regions and carried out condolence activities at the grass-roots level.

Recently, the Guangxi Zhuang Autonomous Region Health and Health Commission, the Guangxi Zhuang Autonomous Region Civil Affairs Department, the Guangxi Zhuang Autonomous Region Disabled Persons’ Federation, the Guangxi Zhuang Autonomous Region Institute for the Prevention and Treatment of Dermatology and other departments prepared warm underwear, milk powder, wheelchairs and other comfort materials and money worth more than 1.3 million yuan for leprosy patients in the leprosy area of the Tingliang Hospital of Guangxi Zhuang Autonomous Region, to send the warmth of the New Year to the patients.

Leprosy has a long history of prevalence in Guangxi. The prevalence and detection rates were as high as 30.04/100000 (1966) and 6.52/100000 (1972) respectively.

According to the introduction of the Health and Health Commission of Guangxi Zhuang Autonomous Region, Guangxi adheres to the prevention and control strategy of “prevention first, prevention and treatment combined, and infection control”, and takes measures such as “inspection, collection, treatment, management, research, and publicity” and “prevention and treatment and rehabilitation simultaneously” to carry out leprosy prevention and control work, taking government leadership, social participation, establishment of institutions, formulation of plans, and prevention first, standardized treatment We will comprehensively carry out leprosy prevention and control in many aspects, such as infection control.

After nearly 70 years of comprehensive prevention and control, Guangxi reached the basic leprosy control index requirements in 1981; In 1986, it met the requirements of leprosy control indicators. In 1997, 100% of the counties (cities, districts) in the region met the target of basically eliminating leprosy. At present, the reported leprosy prevalence rate in Guangxi has dropped to 0.24/100000, down 99.1% from the historical peak.

The Health and Health Commission of Guangxi Zhuang Autonomous Region said that in the past decade, Guangxi has continued to overcome difficulties and continue to consolidate and deepen the effectiveness of prevention and control. Compared with ten years ago, leprosy prevention and treatment showed a trend of “three fewer, one lower and one higher”, that is, the number of new recurrent cases decreased significantly, the number of current cases decreased year by year, the number of children’s cases decreased significantly, the degree of harm decreased significantly, and the early detection rate of cases increased.

Guangxi has carried out a “one-stop service” for the confirmed leprosy patients, integrating the diagnosis, treatment, follow-up, rehabilitation guidance, family physical examination, care and rescue, publicity and training, and focus survey of leprosy patients into one, so as to improve the successful treatment rate. At present, the number of active patients in the region has decreased by 55.56% compared with the previous. The early detection rate of new leprosy patients in Guangxi increased from 49.28% to 80.65%, and the average delay period was shortened by 6 months, which bought time for timely treatment of patients and reduced the incidence of deformity caused by leprosy.

Jindun Medical has long-term scientific cooperation and technology grafting with Chinese universities. With the rich pharmaceutical resources in Jiangsu, we have long-term trade relations with India, Southeast Asia, Korea, Japan and other markets. We also provide marketing and sales services for the whole process from intermediate products to finished APIs. Utilizing Yanghe Chemical’s accumulated resources in fluorine chemistry, we provide special chemical customization services to our partners. Provide process innovation and impurity research services for target customers.

Jindun Medical insists on building a team with dreams, making dignified products, being meticulous, rigorous and realistic, and doing our best to be a trusted partner and friend of our customers! One-stop solution provider, custom R&D and custom manufacturing services for pharmaceutical intermediates and APIs, professional custom pharmaceutical manufacturing (CMO) and custom pharmaceutical development and manufacturing (CDMO) service provider.